Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong
· Delayed Price · Currency is HKD 2.410
+0.110 (4.78%)
Mar 10, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Revenue
Venus Medtech (Hangzhou) had revenue of 187.14M CNY in the half year ending June 30, 2025, a decrease of -26.79%. This brings the company's revenue in the last twelve months to 427.25M, down -8.41% year-over-year. In the year 2024, Venus Medtech (Hangzhou) had annual revenue of 470.83M, down -4.18%.
Revenue (ttm)
427.25M CNY
Revenue Growth
-8.41%
P/S Ratio
2.15
Revenue / Employee
706.20K CNY
Employees
605
Market Cap
1.01B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gaush Meditech | 1.58B |
| Cryofocus Medtech (Shanghai) | 93.32M |
| Broncus Holding | 47.72M |
| Shanghai HeartCare Medical Technology Corporation | 367.02M |
| Vincent Medical Holdings | 869.70M |
| Sisram Medical | 2.71B |
| Suzhou Basecare Medical Corporation | 302.12M |
| Rainmed Medical | 25.60M |